Market Tracker

02/23 5:16pm ET

Depomed Inc (NASDAQ:DEPO)

16.83
Delayed Data
As of 4:00pm ET
 -0.42 / -2.43%
Today’s Change
12.25
Today|||52-Week Range
27.02
-6.60%
Year-to-Date
Argos Plummets 72%, Leads Biotech Movers
Feb 22 / TheStreet.com - Paid Partner Content
3 Companies That Need to Kick Their CEO to the Curb
Feb 19 / MotleyFool.com - Paid Partner Content
Depomed Reports 33% Increase in 2016 Net Product Sales
Feb 21 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close17.25
Today’s open17.16
Day’s range16.73 - 17.31
Volume1,505,071
Average volume (3 months)1,674,643
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)-161.46%
Earnings growth (this year)+45.08%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)-12.20%
P/E ratioNM
Price/Sales3.18
Price/Book3.33

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc-0.55-2.35%
LOXOLoxo Oncology Inc+0.22+0.52%
IPXLImpax Laboratories I...+0.20+1.41%
RGENRepligen Corp+0.08+0.25%
Data as of 4:00pm ET, 02/23/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.24
Annual revenue (last year)$342.7M
Annual profit (last year)-$75.7M
Net profit margin-22.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts